Assoc. Prof. Hilal OĞUZ SOYDİNÇ

Publication Network

Journal articles indexed in SCI, SSCI, and AHCI 42

Do Salivary <i>Cullin7</i> Gene Expression and Protein Levels Provide Advantages over Plasma Levels in Diagnosing Breast Cancer?

Tilgen Yasasever C., Duranyıldız D., Bademler S., Oğuz Soydinç H.

CURRENT ISSUES IN MOLECULAR BIOLOGY , vol.47, no.1, 2025 (SCI-Expanded) Sustainable Development

The Diagnostic Value of circFBXW7, circABCB10, and circ0103552 Levels in Breast Cancer

İLHAN M. B., Ender S., KILIÇ B., ÜÇÜNCÜ M. Z., SERİLMEZ M., TİLGEN YASASEVER C., et al.

CURRENT ISSUES IN MOLECULAR BIOLOGY , vol.46, no.12, pp.14381-14393, 2024 (SCI-Expanded) Sustainable Development

Investigation of the potential of miRNA candidates as non-invasive biomarkers for the diagnosis and follow-up of colorectal cancer

KARABULUT S., ŞEN S., OĞUZ SOYDİNÇ H., Dogan I., TAŞTEKİN D., Karabulut M., et al.

PATHOLOGY RESEARCH AND PRACTICE , vol.254, 2024 (SCI-Expanded) Sustainable Development

Serum folate and vitamin B12 levels in cutaneous melanoma

Tas F., Erturk K., Soydinc H.

JOURNAL OF COSMETIC DERMATOLOGY , vol.20, no.9, pp.3007-3010, 2021 (SCI-Expanded)

Serum 25-Hydroxyvitamin D Level Is Not Associated with Duration and Activity of Disease in Melanoma Patients

Tas F., Erturk K., Oguz S.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL , vol.73, no.7, pp.1126-1129, 2021 (SCI-Expanded) Sustainable Development

CLINICAL UTILITY OF TENSIN 2 LEVELS AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN BREAST CANCER

SERİN K. R., Ucuncu Z., TEMEL M. K., BADEMLER S., Soydinc H. O., KARANLIK H., et al.

ACTA MEDICA MEDITERRANEA , vol.37, no.1, pp.553-558, 2021 (SCI-Expanded) Sustainable Development

The biological role of LYVE-1 in lung cancer

Serilmez M., Karaman S., Soydinc H., Ozgur E., Duranyildiz D.

FEBS OPEN BIO , vol.8, pp.318, 2018 (SCI-Expanded) Sustainable Development

Role of several cytokines and adhesion molecules in the diagnosis and prediction of survival of hepatocellular carcinoma

Iliaz R., Akyuz U., Tekin D., Serilmez M., Evirgen S., Cavus B., et al.

Arab Journal of Gastroenterology , vol.17, no.4, pp.164-167, 2016 (SCI-Expanded)

Circulating serum levels of angiopoietin-1 and angiopoietin-2 in nasopharynx and larynx carcinoma patients

Guveli M. E., Duranyildiz D., Karadeniz A., Bilgin E., Serilmez M., Soydinc H. O., et al.

TUMOR BIOLOGY , vol.37, no.7, pp.8979-8983, 2016 (SCI-Expanded) Sustainable Development

Clinical significance of interleukin-4 and interleukin-18 levels in aggressive non-Hodgkin's lymphoma patients

Soydinc H., Guney N., Basaran M., Duranyildiz D., Yasasever V.

GENETICS AND MOLECULAR RESEARCH , vol.15, no.3, 2016 (SCI-Expanded)

Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer

KARABULUT M., ALIS H., AFSAR C. U., Karabulut S., KOCATAS A., Oguz H., et al.

BIOMEDICINE & PHARMACOTHERAPY , vol.73, pp.140-146, 2015 (SCI-Expanded) Sustainable Development

Clinical significance of serum hepatocyte growth factor (HGF) levels in hepatocellular carcinoma

Karabulut S., Tas F., Akyuz F., Ormeci A., Serilmez M., Soydinc H. O., et al.

TUMOR BIOLOGY , vol.35, no.3, pp.2327-2333, 2014 (SCI-Expanded) Sustainable Development

Effects of Intraperitoneal Bevacizumab Administration on Colonic Anastomosis and Early Postoperative Adhesion Formation

Karanlik H., KURT A., Kunduz E., Serin K. R., Saglam S., Soydinc H. O., et al.

SURGICAL INNOVATION , vol.20, no.6, pp.559-565, 2013 (SCI-Expanded)

For Which Cancer Types can Neuron-Specific Enolase be Clinically Helpful in Turkish Patients?

Bilgin E., Dizdar Y., Serilmez M., Soydinc H. O., Yasasever C., Duranyildiz D., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.14, no.4, pp.2541-2544, 2013 (SCI-Expanded) Sustainable Development

Markers of Bone Metastases in Breast and Lung Cancers

Bilgin E., Yasasever V., Soydinc H. O., Yasasever C., Ozturk N., Duranyildiz D.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.9, pp.4331-4334, 2012 (SCI-Expanded) Sustainable Development

Utility of Serum and Urine uPAR Levels for Diagnosis of Breast Cancer

Soydinc H. O., Duranyildiz D., Guney N., Derin D., Yasasever V.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.6, pp.2887-2889, 2012 (SCI-Expanded) Sustainable Development

Matrix metalloproteinase-9 decreased after chemotherapy in patients with non-small cell lung cancer

Ertan E., Soydinc H., YAZAR A., Ustuner Z., Tas F., Yasasever V.

TUMORI , vol.97, no.3, pp.286-289, 2011 (SCI-Expanded) Sustainable Development

Lack of Diagnostic Potential of Dickkopf-1 in Colon and Rectum Cancers

Soydinc H. O., Duranyildiz D., Camlica H., Oral E. N., Yasasever V.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.12, no.12, pp.3187-3189, 2011 (SCI-Expanded) Sustainable Development

Variations in systemic biomarkers of oxidative/nitrosative stress and DNA damage before and during the consequent two cycles of chemotherapy in breast cancer patients

Atukeren P., Yavuz B., Soydinc H. O., Purisa S., Camlica H., Gumustas M. K., et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE , vol.48, no.10, pp.1487-1495, 2010 (SCI-Expanded) Sustainable Development

Serum levels of angiogenic factors in early breast cancer remain close to normal

Duranyildiz D., Camlica H., Soydinc H. O., Derin D., Yasasever V.

BREAST , vol.18, no.1, pp.26-29, 2009 (SCI-Expanded) Sustainable Development

Serum Levels of Interleukin-6 and Interleukin-10 in Turkish Patients with Aggressive Non-Hodgkin's Lymphoma

Güney N., Soydinc H. O., Basaran M., BAVBEK S., Derin D., Camlica H., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.10, no.4, pp.669-674, 2009 (SCI-Expanded)

Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma

Tas F., Duranyildiz D., Oguz H., Camlica H., Yasasever V., Topuz E.

MEDICAL ONCOLOGY , vol.25, no.4, pp.431-436, 2008 (SCI-Expanded)

Effect of zoledronic acid on serum angiogenic factors in patients with bone metastases

Tas F., Duranyildiz D., Oguz H., Camlica H., Yasasever V., Topuz E.

MEDICAL ONCOLOGY , vol.25, no.3, pp.346-349, 2008 (SCI-Expanded) Sustainable Development

Serum levels of intercellular adhesion molecule ICAM-1 and E-selectin in advanced stage non-small cell lung cancer

Guney N., Soydinc H. O., Derin D., Tas F., Camlica H., Duranyildiz D., et al.

MEDICAL ONCOLOGY , vol.25, no.2, pp.194-200, 2008 (SCI-Expanded) Sustainable Development

Effect of maximum-tolerated doses and low-dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin-1 levels in patients with advanced nonsmall cell lung cancer

Tas F., Duranyildiz D., Soydinc H. O., Cicin I., Selam M., Uygun K., et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.61, no.5, pp.721-725, 2008 (SCI-Expanded) Sustainable Development

The role of serum vascular endothelial growth factor and matrix metalloproteinase-9 in predicting response to chemotherapy in patients with advanced nonsmall cell lung cancer

Yazar A., SOYDINC H., Ertan E., Yasasever V., Tas F.

SOUTHERN MEDICAL JOURNAL , vol.101, no.3, pp.327-328, 2008 (SCI-Expanded) Sustainable Development

The diagnostic value of macrophage migration inhibitory factor (MIF) in gastric cancer

Camlica H., Duranyildiz D., Oguz H., Oral E. N., Yasasever V.

PATHOLOGY & ONCOLOGY RESEARCH , vol.14, no.1, pp.79-83, 2008 (SCI-Expanded) Sustainable Development

Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer

Derin D., Soydinc H. O., Guney N., Tas F., Camlica H., Duranyildiz D., et al.

LUNG CANCER , vol.59, no.2, pp.240-245, 2008 (SCI-Expanded) Sustainable Development

Macrophage migration inhibitory factor in cancer

Yasasever V., Camlica H., Duranyildiz D., Oguz H., Tas F., Dalay N.

CANCER INVESTIGATION , vol.25, no.8, pp.715-719, 2007 (SCI-Expanded) Sustainable Development

Serum IL-8 and IL-12 levels in breast cancer

Derin D., SOYDINC H. O., Güney N., Tas F., Çamlıca H., Duranyıldız D., et al.

MEDICAL ONCOLOGY , vol.24, no.2, pp.163-168, 2007 (SCI-Expanded) Sustainable Development

Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients

Tas F., Duranyıldız D., OĞUZ H., Çamlıca H., Yasasever V., Topuz E.

MELANOMA RESEARCH , vol.16, no.5, pp.405-411, 2006 (SCI-Expanded) Sustainable Development

Serum vascular endothelial growth factor (VEGF) and Bcl-2 levels in advanced stage non-small cell lung cancer

Tas F., Duranyıldız D., OĞUZ H., Çamlıca H., Yasasever V., Topuz E.

CANCER INVESTIGATION , vol.24, no.6, pp.576-580, 2006 (SCI-Expanded) Sustainable Development

Serum vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) levels in small cell lung cancer

Tas F., DURANYILDIZ D., Oguz H., CAMLICA H., YASASEVER V., TOPUZ E.

CANCER INVESTIGATION , vol.24, no.5, pp.492-496, 2006 (SCI-Expanded) Sustainable Development

Serum MMP-9 and TIMP-1 values in lung cancer

Hilal O. S., Yildiz D. D., Dalay N., Camlica H., Saglam K. E., Yasasever V.

TUMOR BIOLOGY , vol.27, pp.82, 2006 (SCI-Expanded) Sustainable Development

The value of serum bcl-2 levels in advanced epithelial ovarian cancer.

TAS F., DURANYILDIZ D., OGUZ H., CAMLICA H., Yasasever V., TOPUZ E.

Medical oncology (Northwood, London, England) , vol.23, no.2, pp.213-7, 2006 (SCI-Expanded) Sustainable Development

Serum and urine survivin levels in breast cancer

Güney N., SOYDINE H., DEFIN D., Tas F., Çamlıca H., Duranyıldız D., et al.

MEDICAL ONCOLOGY , vol.23, no.3, pp.335-339, 2006 (SCI-Expanded) Sustainable Development

Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in patients with malignant melanoma

TAS F., DURANYILDIZ D., OGUZ H., DISCI R., KURUL S., Yasasever V., et al.

MEDICAL ONCOLOGY , vol.22, no.1, pp.39-44, 2005 (SCI-Expanded) Sustainable Development

The value of serum Bcl-2 levels in advanced lung cancer patients

TAS F., DURANYILDIZ D., OGUZ H., CAMLICA H., ORAL E., Yasasever V., et al.

MEDICAL ONCOLOGY , vol.22, no.2, pp.139-143, 2005 (SCI-Expanded) Sustainable Development

Apoptosis of lymphocytes in peripheral blood of patients with melanoma

TAS F., DURANYILDIZ D., ARGON A., GUZ H., CAMLICA H., Yasasever V., et al.

MEDICAL ONCOLOGY , vol.22, no.2, pp.177-181, 2005 (SCI-Expanded) Sustainable Development

Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer

TAS F., DURANYILDIZ D., ARGON A., OGUZ H., CAMLICA H., Yasasever V., et al.

MEDICAL ONCOLOGY , vol.22, no.4, pp.353-358, 2005 (SCI-Expanded) Sustainable Development

The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma

TAS F., OGUZ H., ARGON A., DURANYILDIZ D., CAMLICA H., Yasasever V., et al.

MEDICAL ONCOLOGY , vol.22, no.3, pp.241-246, 2005 (SCI-Expanded)

Serum bcl-2 and survivin levels in melanoma

TAS F., DURANYILDIZ D., ARGON A., OGUZ H., CAMLICA H., Yasasever V., et al.

MELANOMA RESEARCH , vol.14, no.6, pp.543-546, 2004 (SCI-Expanded)

Articles Published in Other Journals 16

Do Salivary Cullin7 Gene Expression and Protein Levels Provide Advantages over Plasma Levels in Diagnosing Breast Cancer?

Tilgen Yasasever C., Duranyıldız H. D., Bademler S., Oğuz Soydinç H.

Current Issues in Molecular Biology , vol.47, no.19, pp.1-13, 2025 (Peer-Reviewed Journal)

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma

Naziye A. K., Paksoy N., Ferhatoglu F., Aydin E., Dogan I., Bektas E., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.36, pp.438-445, 2021 (ESCI)

Effect of intraperitoneal cetuximab administration on colonic anastomosis and early postoperative adhesion formation in a rat model

Kurt A., Karanlik H., Soylu S., Ozgur I., Soydinc H. O., Duranyildiz D., et al.

TURKISH JOURNAL OF SURGERY , vol.32, no.3, pp.157-161, 2016 (ESCI)

Pankreas adenokanserli hastalarda serum ekstrasellülermatriks proteinlerininprognostik ve prediktif değerinin araştırılması

KARABULUT S., KARABULUT M., ALIŞ H., DAĞOĞLU R. N., TAMBAŞ M., KAPAN S., et al.

MEDICAL JOURNAL OF BAKIRKOY , vol.12, no.1, pp.24-32, 2016 (Scopus)

The predictive and prognostic value evaluation of serum extracellular matrix proteins levels in patients with pancreas adenocarcinoma

Karabulut S., KARABULUT M., ALIS H., Dagoglu N., Tambas M., KAPAN S., et al.

MEDICAL JOURNAL OF BAKIRKOY , no.1, pp.24-32, 2016 (ESCI) Sustainable Development

Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer

Karabulut M., Alis H., Bas K., Karabulut S., Afsar C. U., Oguz H., et al.

MOLECULAR AND CLINICAL ONCOLOGY , vol.3, no.6, pp.1255-1267, 2015 (ESCI) Sustainable Development

Küçük Hücreli Akciğer Kanserinde Anjiogenik Faktörler (VEGF, VEGFR-1, VEGFR-2)

OĞUZ SOYDİNÇ H., DURANYILDIZ D., BILGIN E., TAŞ F., YASASEVER V.

TÜRK ONKOLOJİ DERGİSİ , vol.27, no.2, pp.55-61, 2012 (Scopus) Sustainable Development

Angiogenic factors in small veil lung cancer (VEGF, VEGFR-1, VEGFR-2)

OĞUZ SOYDİNÇ H., DURANYILDIZ H. D., Bilgin E., TAŞ F., Yasasever V.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.27, no.2, pp.55-61, 2012 (ESCI) Sustainable Development

Determination of serum CRP, VEGF, Leptin, CK-MB, CA-15-3 and IL-6 levels for malignancy prediction in adnexal masses

Sen S., Kuru O., Akbayir O., Oguz H., Yasasever V., Berkman S.

JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION , vol.12, no.4, pp.214-219, 2011 (ESCI)

Akciğer Kanserinde Hematolojik Parametreler

SERİLMEZ M., OĞUZ SOYDİNÇ H., CAMLICA H., TOPUZ E., DURANYILDIZ D.

TÜRK ONKOLOJİ DERGİSİ , vol.25, no.3, pp.87-92, 2010 (Scopus) Sustainable Development

Hematological parameters in lung cancer

SERİLMEZ M., OĞUZ SOYDİNÇ H., Camlica H., Topuz E., DURANYILDIZ H. D.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.25, no.3, pp.87-92, 2010 (ESCI) Sustainable Development

Evre IV küçük hücreli dışı akciğer kanserinde serum vasküler endotelyal büyüme faktörü ve Bcl-2 düzeyleri ve aralarındaki ilişki

ERTAN E., OĞUZ SOYDİNÇ H., YAZAR A., ÖZGÜL A., TAŞ F., YASASEVER V., et al.

TÜRK ONKOLOJİ DERGİSİ , vol.22, no.2, pp.76-81, 2007 (Scopus) Sustainable Development

The levels of serum vascular endothelial growth factor and Bcl-2 and association between them in stage IV non-small cell lung cancer

Yazar E. E., OĞUZ SOYDİNÇ H., Yazar A., Ozgul A., TAŞ F., Yasasever V., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.22, no.2, pp.76-81, 2007 (ESCI) Sustainable Development

Matriks Metalloproteinazlar ve Akciğer Kanseri

OĞUZ H., Çamlıca H., DURANYILDIZ H. D., KAYTAN SAĞLAM E., TAŞ F., YASASEVER F. V., et al.

TÜRK ONKOLOJİ DERGİSİ , vol.21, no.2, pp.53-56, 2006 (Peer-Reviewed Journal) Sustainable Development

Matrix metalloproteinases and lung cancer

OĞUZ SOYDİNÇ H., Camlica H., DURANYILDIZ H. D., KAYTAN SAĞLAM E., TAŞ F., Yasasever V., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.21, no.2, pp.53-56, 2006 (ESCI) Sustainable Development

MALIGNANT MELANOMA AND SURVIVIN

Oguz H., DURANYILDIZ H. D., Camlica H., TAŞ F., Yasasever V., Topuz E.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.20, no.1, pp.27-29, 2005 (ESCI)

Papers Presented at Peer-Reviewed Scientific Conferences 75

Prognostic Importance of BRAF and PTEN Proteins in Patients with Malignant Melanoma

Bilgin Doğru E., Tilgen Yasasever C., Serilmez M., Taş F., Duranyıldız H. D., Oğuz Soydinç H.

IX. INTERNATIONAL CONGRESS OF MOLECULAR MEDICINE “MOLECULAR MEDICINE IN LIFE SCIENCES”, İstanbul, Turkey, 18 - 20 December 2023, pp.1, (Summary Text)

MEME KANSERİNDE SERUM DOUBLECORTİN-LİKE KİNASE 1DÜZEYLERİ

ÖZTÜRK N., KARADENİZ E., DURANYILDIZ H. D., SERİLMEZ M., OĞUZ SOYDİNÇ H., ÖZTÜRK G., et al.

UluslararasıLaboratuvar Tıbbıve XX. Ulusal KlinikBiyokimya Kongresi, Turkey, 25 - 26 December 2020, (Summary Text)

Tensin-2 Molekülünün Meme Kanserli Hastalardaki Önemi

TİLGEN YASASEVER C., BİLGİN E., serilmez m., OĞUZ SOYDİNÇ H., BADEMLER S., KARANLIK H.

29. Ulusal Biyokimya Kongresi Bodrum-Muğla, Muğla, Turkey, 26 - 30 October 2018, (Summary Text) Sustainable Development

The biological role of AKT serine/threonine kinase 2 in lung cancer

Serilmez M., Karaman S., Soydinc H. O., Yasasever C., Bilgin E., Duranyildiz D., et al.

ECCO European Cancer Congress, Amsterdam, Netherlands, 27 - 30 January 2017, vol.72, (Summary Text) Sustainable Development

Clinical significance of serum cmet and hgf protein and mRNA levels in lung cancer.

SERİLMEZ M., ÖZGÜR E., KARAMAN Ş., OĞUZ SOYDİNÇ H., DURANYILDIZ D., YASASEVER V.

41st Congress of the Federation of European Biochemical Societies (FEBS), İzmir, Turkey, 3 - 08 September 2016, pp.1, (Full Text) Sustainable Development

Do serum nestin levels have a diagnostic effect in patients with colorectal cancer?

KARABULUT S., Serilmez M., Soydinc H., Duranyildiz D.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Turkey, 3 - 08 September 2016, vol.283, pp.115, (Summary Text) Sustainable Development

Meme Kanserli Hastalarda NGAL ve MMP-9'un Kemoterapi İle Değişimi

OĞUZ SOYDİNÇ H., SERİLMEZ M., ŞEN F., DURANYILDIZ D., YASASEVER V.

6. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 23 - 27 March 2016, pp.1, (Full Text) Sustainable Development

Over Kanserli Hastalarda Prolaktin ve Interlökin-10’un Rolü”

SERİLMEZ M., OĞUZ SOYDİNÇ H., KURU O., DURANYILDIZ D., YASASEVER V.

6. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 23 - 27 March 2016, pp.1, (Full Text) Sustainable Development

Beyin Tümörlü Hastalarda HMGB1 Düzeyinin Belirlenmesi

OĞUZ SOYDİNÇ H., YASASEVER V., GÖRGÜN Ö. N. H., AKŞİT E., MERAL R.

22. Ulusal Kanser Kongresi, Antalya, Turkey, 23 - 27 March 2016, pp.1, (Full Text)

Do serum nectin-2 levels have a prognostic effect in patients with colorectal cancer?

Serilmez M., Duranyildiz D., Soydinc H., Karabulut S., Yasasever V.

40th Congress of the Federation-of-European-Biochemical-Societies (FEBS) - The Biochemical Basis of Life, Berlin, Germany, 4 - 09 July 2015, vol.282, pp.257, (Summary Text) Sustainable Development

Serum NEDD9 levels may have prognostic roles in patients with gastric cancer

Duranyildiz D., Serilmez M., Soydinc H. O., Karabulut S., Yasasever V.

40th Congress of the Federation-of-European-Biochemical-Societies (FEBS) - The Biochemical Basis of Life, Berlin, Germany, 4 - 09 July 2015, vol.282, pp.253-254, (Summary Text) Sustainable Development

Serum MCP-1 in pancreatic adenocarcinoma

Soydinc H., Serilmez M., Karabulut S., Duranyildiz D., Yasasever V.

40th Congress of the Federation-of-European-Biochemical-Societies (FEBS) - The Biochemical Basis of Life, Berlin, Germany, 4 - 09 July 2015, vol.282, pp.261, (Summary Text)

Kolorektal Kanserli Hastalarda Serum Epidermal Büyüme Faktör Reseptörü (EGFR) Seviyelerinin Değerlendirilmesi ve Klinikopatolojik Özelliklerle Olan Korelasyonu

KARABULUT S., ALIS H., KARABULUT M., GÜNALDI M., OĞUZ SOYDİNÇ H., ERTÜRK K., et al.

21. Ulusal Kanser Kongresi, Antalya, Turkey, 22 - 26 April 2015, pp.1, (Full Text) Sustainable Development

Kolorektal Kanser Tespitinde Serum İnterlökin-17 (Il-17) Seviyelerinin Diagnostik Değeri Var Mıdır?

ERTÜRK K., KARABULUT M., ALIS H., GÜNALDI M., KARABULUT S., ÇELEBİ K., et al.

21. Ulusal Kanser Kongresi, Antalya, Turkey, 22 - 26 April 2015, pp.1, (Full Text) Sustainable Development

Serum NEDD9 Seviyeleri Gastrik Kanserli Hastalarda Prognostik Rolü

GÜNALDI M., KARABULUT M., ALIS H., KARABULUT S., KİZİR A., OĞUZ SOYDİNÇ H., et al.

21. Ulusal Kanser Kongresi, Antalya, Turkey, 22 - 26 April 2015, pp.1, (Full Text) Sustainable Development

Serum Hepatosit Büyüme Faktörünün Akciğer Kanserli Hastalarda Tanısal Değeri

ŞEN F., BOZBEY H., ÇİFTÇİ R., KILIÇ L., YILDIZ İ., TAŞTEKİN D., et al.

21. Ulusal Kanser Kongresi, Antalya, Turkey, 22 - 26 April 2015, pp.1, (Full Text) Sustainable Development

Hepatosellüler karsinomda galektin-3 ve fibronektin molekülleri yeni bir tümör belirteci olabilir mi?

SERİLMEZ M., AKYÜZ M., TAŞTEKİN D., OĞUZ SOYDİNÇ H., DURANYILDIZ D.

21. Ulusal Kanser Kongresi, Antalya, Turkey, 22 - 26 April 2015, pp.1, (Full Text)

MALİGN VE BENiGN OVER KiTLELi HASTA SERUMLARINDA GLiKODELiN-A DÜZEYLERiNiN BELİRLENMESi

OĞUZ SOYDİNÇ H., KURU O., BILGIN E., BERKMAN S., YASASEVER V.

21. ULUSAL KANSER KONGRESİ, Antalya, Turkey, 22 - 16 April 2015, pp.637, (Full Text)

Beyin Tümörlü Hastalarda Galectin-3 BP Düzeyleri

AKŞİT E., GÜVELİ M. E., YASASEVER C. T., OĞUZ SOYDİNÇ H., YASASEVER V.

21. Ulusal Kanser Kongresi, Antalya, Turkey, 22 - 26 April 2015, pp.1, (Full Text)

VEGF-C,ANGIOPOIETIN-1 and Interferon Gamma-Inducible Protein-10 (IP-10) levels in lung and breast cancer

OĞUZ SOYDİNÇ H., DURANYILDIZ D., ORAL E. N., YASASEVER V.

IFCC WorldLab Istanbul 2014, İstanbul, Turkey, 22 - 26 June 2014, pp.1, (Full Text) Sustainable Development

Leptin levels in breast cancer

Serilmez M., Soydinc H. O., Bilgin E., Yasasever C., Duranyildiz D.

22nd IUBMB Congress/37th FEBS Congress, Sevilla, Spain, 4 - 09 September 2012, vol.279, pp.101-102, (Summary Text) Sustainable Development

Significance of NSE in various cancer types

Bilgin E., Soydinc H. O., Yasasever C. T., Serilmez M., Yasasever V.

22nd IUBMB Congress/37th FEBS Congress, Sevilla, Spain, 4 - 09 September 2012, vol.279, pp.101, (Summary Text) Sustainable Development

Mide karsinomlarında sitokin ve epidermal büyüme faktörü (EGFR) düzeyleri

SERİLMEZ M., OĞUZ SOYDİNÇ H., CICIN I., UZUNOĞLU S., DURANYILDIZ D.

19.Ulusal Kanser Kongresi, Antalya, Turkey, 20 - 24 April 2011, pp.1, (Full Text)

Kolon ve rektum karsinomlu hastalarda EGFR IL-6 ve IL-10 düzeyleri

SERİLMEZ M., OĞUZ SOYDİNÇ H., KILIÇ L., UZUNOĞLU S., TAŞ F., DURANYILDIZ D.

19.Ulusal Kanser Kongresi, Antalya, Turkey, 20 - 24 April 2011, pp.1, (Full Text)

Endojen ve Eksojen Melatoninin Hiperbarik Oksijen Tedavisi ile Birlikte Gentamisin Nefrotoksisitesi Üzerine Etkileri

ZEREN S., OĞUZ SOYDİNÇ H., OLGAÇ V., AKTAŞ Ş.

36. Ulusal Fizyoloji Kongresi, Edirne, Turkey, 14 - 17 September 2010, pp.1, (Full Text)

Hyperbaric Oxygen Therapy and Melatonin Co-administration in Gentamicin Induced Nephrotoxicity

ZEREN S., OĞUZ SOYDİNÇ H., OLGAÇ V., AKTAŞ Ş.

36th Annual Scientific Meeting of European Underwater and Baromedical Society (EUBS 2010), İstanbul, Turkey, 14 - 18 September 2010, pp.1, (Full Text)

Renal function tests in childhood cancer

OĞUZ SOYDİNÇ H., SERİLMEZ M., YASASEVER V.

The 5th APOCP Conference, İstanbul, Turkey, 3 - 07 April 2010, pp.1, (Full Text) Sustainable Development

The levels of plasma fibrinogen in cancer patients

SERİLMEZ M., OĞUZ SOYDİNÇ H., DURANYILDIZ D.

The 5th APOCP Conference, İstanbul, Turkey, 3 - 07 April 2010, pp.1, (Full Text) Sustainable Development

Akciğer kanserli hastalarda kemoterapi ve radyoterapinin hematolojik parametreler üzerine etkisi

SERİLMEZ M., OĞUZ SOYDİNÇ H., TAŞ F., DURANYILDIZ D.

21. Ulusal Biokimya Kongresi, İstanbul, Turkey, 28 - 31 October 2009, pp.1, (Full Text) Sustainable Development

Platin-bazlı kemoterapi alan hastalarda üre- kreatinin değerleri

OĞUZ SOYDİNÇ H., SERİLMEZ M., TAŞ F., YASASEVER V.

21. Ulusal Biokimya Kongresi, İstanbul, Turkey, 28 - 31 October 2009, pp.1, (Full Text)

leri Evre Küçük Hücreli Dışı Akciğer Kanserinde Adezyon Molekülü ICAM-1 ve E-Selectin’in Serum Düzeyleri

GUNEY N., OĞUZ SOYDİNÇ H., DERIN D., TAŞ F., CAMLICA H., DURANYILDIZ D., et al.

XVIII. Ulusal Kanser Kongresi, Antalya, Turkey, 21 - 26 April 2009, pp.1, (Full Text) Sustainable Development

Akciğer Kanserinde IL-12’nin Yeri

DURANYILDIZ D., OĞUZ SOYDİNÇ H., CAMLICA H., TAŞ F., YASASEVER V.

XVIII. Ulusal Kanser Kongresi, Antalya, Turkey, 21 - 26 April 2009, pp.1, (Full Text) Sustainable Development

Non Hodgkin Lenfomalı Hastalarda Serum IL-2R Değerleri

OĞUZ SOYDİNÇ H., DURANYILDIZ D., GUNEY N., CAMLICA H., BAŞARAN M., YASASEVER V.

XVIII. Ulusal Kanser Kongresi, Antalya, Turkey, 21 - 26 April 2009, pp.1, (Full Text)

Akciğer Kanserinde IL-6 ve IL-1beta

YASASEVER V., DURANYILDIZ D., OĞUZ SOYDİNÇ H., CAMLICA H., TAŞ F.

XVIII. Ulusal Kanser Kongresi, Antalya, Turkey, 21 - 26 April 2009, pp.1, (Full Text) Sustainable Development

Meme Kanseri ve Sitokinler

OĞUZ SOYDİNÇ H., DURANYILDIZ D., GUNEY N., DERIN D., CAMLICA H., YASASEVER V.

XVIII. Ulusal Kanser Kongresi, Antalya, Turkey, 21 - 26 April 2009, pp.1, (Full Text) Sustainable Development

Survivin Levels in Cancer

OĞUZ SOYDİNÇ H., DURANYILDIZ D., CAMLICA H., TAŞ F., YASASEVER V.

XXIII. IATMO Conference: Cancer, Cell Death and Differentiation, Trieste, Italy, 19 - 21 October 2007, pp.1, (Full Text) Sustainable Development

Bone Markers in Bone Metastases

OĞUZ SOYDİNÇ H., DURANYILDIZ D., CAMLICA H., TAŞ F., YASASEVER V.

XXIII. IATMO Conference: Cancer, Cell Death and Differentiation, Trieste, Italy, 19 - 21 October 2007, pp.1, (Full Text)

Gastrointestinal Sistem Kanserlerinde IL-12’nin Rolü

DURANYILDIZ D., YAZAR A., KAYTAN SAĞLAM E., OĞUZ SOYDİNÇ H., CAMLICA H., YASASEVER V.

XVII. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2007, pp.1, (Full Text) Sustainable Development

Gastrointestinal Sistem Kanserlerinde MIF’in Önemi

OĞUZ SOYDİNÇ H., YAZAR A., KAYTAN SAĞLAM E., CAMLICA H., DURANYILDIZ D., YASASEVER V.

XVII. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2007, pp.1, (Full Text) Sustainable Development

IL-13 ve Akciğer Kanseri

OĞUZ SOYDİNÇ H., TAŞ F., UYGUN K., CICIN I., SELAM M., CAMLICA H., et al.

XVII. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2007, pp.1, (Full Text) Sustainable Development

Kemik Metastazlarinda Osteokalsin

OĞUZ SOYDİNÇ H., CAMLICA H., DURANYILDIZ D., TAŞ F., YASASEVER V.

XVII. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2007, pp.1, (Full Text)

989 Vakada PSA Düzeylerinin İstatistiksel Değerlendirilmesi

CAMLICA H., DIZDAR Y., OĞUZ SOYDİNÇ H.

XVII. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2007, pp.1, (Full Text)

Evre IV Küçük Hücreli dışı Akciğer Kanserinde Serum Vasküler Endotelyal Büyüme Faktörü ve Bcl-2 Düzeyleri Arasındaki İlişki’

ERTAN E., TAŞ F., OĞUZ SOYDİNÇ H., YAZAR A., YASASEVER V., ÖZGÜL A., et al.

XVII. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2007, pp.1, (Full Text) Sustainable Development

Akciğer Kanserinde Anjiogenik Faktörler’

TAŞ F., OĞUZ SOYDİNÇ H., UYGUN K., CICIN I., SELAM M., CAMLICA H., et al.

XVII. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2007, pp.1, (Full Text) Sustainable Development

Malign Melanomda MIF’in Önemi’

DURANYILDIZ D., OĞUZ SOYDİNÇ H., CAMLICA H., TAŞ F., YASASEVER V.

XVII. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2007, pp.1, (Full Text)

Kemik Metastazlarinda Osteoprotegerin

DURANYILDIZ D., OĞUZ SOYDİNÇ H., CAMLICA H., TAŞ F., YASASEVER V.

XVII. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2007, pp.1, (Full Text)

The Reference Values of VEGF and VEGF-R1 in Cancer Patients

CAMLICA H., OĞUZ SOYDİNÇ H., TOPUZ E.

II. Ulusal Moleküler Tıp Kongresi, İstanbul, Turkey, 24 March - 26 April 2007, pp.1, (Full Text) Sustainable Development

The Role of IL-13 in Lung Cancer

OĞUZ SOYDİNÇ H., DURANYILDIZ D., CAMLICA H., TAŞ F., YASASEVER V.

II. Ulusal Moleküler Tıp Kongresi, İstanbul, Turkey, 24 March - 26 April 2007, pp.1, (Full Text) Sustainable Development

The Role of UPAR in Lung Cancer

DURANYILDIZ D., OĞUZ SOYDİNÇ H., CAMLICA H., TAŞ F., YASASEVER V.

II. Ulusal Moleküler Tıp Kongresi, İstanbul, Turkey, 24 March - 26 April 2007, pp.1, (Full Text) Sustainable Development

Sindirim Sistemi Kanserlerinde Yeni Tümör Belirleyicisi MIF’in Tanı Gücü’

CAMLICA H., OĞUZ SOYDİNÇ H., DİŞÇİ R., TOPUZ E., YASASEVER V.

IX. Ulusal Biyoistatistik Kongresi, Zonguldak, Turkey, 6 - 09 September 2006, pp.1, (Full Text) Sustainable Development

The Role of uPAR in Breast Cancer: A Proteolytic System Component

OĞUZ SOYDİNÇ H., CAMLICA H., DURANYILDIZ D., GUNEY N., DERIN D., TAŞ F., et al.

31st FEBS Congress “Molecules in Health and Disease, İstanbul, Turkey, 24 - 29 June 2006, pp.1, (Full Text) Sustainable Development

İleri Evre Over Kanserinde Leptinin Önemi

OĞUZ SOYDİNÇ H., CAMLICA H., DURANYILDIZ D., TAŞ F., TOPUZ E., YASASEVER V.

I.Tıbbi Onkoloji Kongresi, Antalya, Turkey, 29 March - 02 April 2006, pp.1, (Full Text) Sustainable Development

Meme Kanserinde IL-8 ve IL-12 Düzeyleri

DERIN D., OĞUZ SOYDİNÇ H., GUNEY N., TAŞ F., CAMLICA H., YASASEVER V., et al.

I.Tıbbi Onkoloji Kongresi, Antalya, Turkey, 29 March - 02 April 2006, pp.1, (Full Text) Sustainable Development

Malign Melanomda Anjiogenik Faktörler

OĞUZ SOYDİNÇ H., CAMLICA H., DURANYILDIZ D., TAŞ F., TOPUZ E., YASASEVER V.

I.Tıbbi Onkoloji Kongresi, Antalya, Turkey, 29 March - 02 April 2006, pp.1, (Full Text)

Epitelyal Over Kanserli Hastalarda Serum Leptin Düzeyinin Ca125 ve Sağkalım ile İlişkisi

YAZAR A., TAŞ F., OĞUZ SOYDİNÇ H., CAMLICA H., ERALP Y., SAİP P., et al.

I.Tıbbi Onkoloji Kongresi, Antalya, Turkey, 29 March - 02 April 2006, pp.1, (Full Text) Sustainable Development

İleri Evre Küçük Hücreli Dışı Akciğer Kanserinde Matriks Metalloproteinaz-9, Vasküler Endotelyal Büyüme Faktör ve bcl-2 Düzeylerinin Prognoz ve Tedavi ile İlişkileri

YAZAR A., TAŞ F., OĞUZ SOYDİNÇ H., ERTAN E., YASASEVER V., CAMLICA H., et al.

I.Tıbbi Onkoloji Kongresi, Antalya, Turkey, 29 March - 02 April 2006, pp.1, (Full Text) Sustainable Development

Malign Melanomda Anjiogenik Faktörler ile Prognostik Faktörlerin İlişkisi

OĞUZ SOYDİNÇ H., DURANYILDIZ D., CAMLICA H., TAŞ F., TOPUZ E., YASASEVER V.

I.Tıbbi Onkoloji Kongresi, Antalya, Turkey, 29 March - 02 April 2006, pp.1, (Full Text)

İleri Evre Küçük Hücreli Dışı Akciğer Kanserinde Matriks Metalloproteinaz-9 Düzeyinin Tedavi ile Değişiminin Tedaviye Cevap Ve Sağkalım Ile Ilişkisi

YAZAR A., TAŞ F., OĞUZ SOYDİNÇ H., ERTAN E., YASASEVER V., CAMLICA H., et al.

I.Tıbbi Onkoloji Kongresi, Antalya, Turkey, 29 March - 02 April 2006, pp.1, (Full Text) Sustainable Development

Malign Melanomda VEGF, MMP-3 ve Bcl-2 Düzeyleri

OĞUZ SOYDİNÇ H., DURANYILDIZ D., CAMLICA H., TAŞ F., TOPUZ E., YASASEVER V.

I.Tıbbi Onkoloji Kongresi, Antalya, Turkey, 29 March - 02 April 2006, pp.1, (Full Text)

Meme Kanserinde Serum ve İdrar Survivin Değerleri

GUNEY N., OĞUZ SOYDİNÇ H., DERIN D., TAŞ F., CAMLICA H., DURANYILDIZ D., et al.

I.Tıbbi Onkoloji Kongresi, Antalya, Turkey, 29 March - 02 April 2006, pp.1, (Full Text) Sustainable Development

Serum and urine survivin levels in breast cancer

Güney N., SOYDINE H., Derin D., Tas F., Çamlıca H., Duranyıldız D., et al.

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.89, (Summary Text) Sustainable Development

Leptin and BCL-2 in addition to CA 12-5: Is it a sensitive and accurate way of diagnosis?

Çamlıca H., OĞUZ H., Disci R., Topuz E., Yasasever V.

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.65, (Summary Text)

Serum MMP-9 and TIMP-1 Values in Lung Cancer

OĞUZ SOYDİNÇ H., DURANYILDIZ D., DALAY N., CAMLICA H., KAYTAN SAĞLAM E., YASASEVER V.

ISOBM 2005 The XXXIII Meeting of the International Society for Oncodevelopmental Biology and Medicine, Rhodes, Greece, 24 - 28 September 2005, pp.1, (Full Text) Sustainable Development

Serum levels of leptin and proinflammatory cytokinesin advanced stage non-small cell lung cancer.

Topuz E., Tas F., Argon A., Yildiz D., Oguz H., Yasasever V., et al.

41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 13 - 17 May 2005, vol.23, (Summary Text) Sustainable Development

Serum Levels of Leptin and Proinflammatory Cytokines in Advanced Stage Non-small Cell Lung Cancer

TOPUZ E., TAŞ F., ARGON A., DURANYILDIZ D., OĞUZ SOYDİNÇ H., YASASEVER V., et al.

2005 ASCO Annual Meeting, Orlando/Florıda, United States Of America, 12 - 17 May 2005, pp.1, (Full Text) Sustainable Development